RECTAL CANCER RECURRENT
Clinical trials for RECTAL CANCER RECURRENT explained in plain language.
Never miss a new study
Get alerted when new RECTAL CANCER RECURRENT trials appear
Sign up with your email to follow new studies for RECTAL CANCER RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Rectal cancer combo trial pulled before starting
Disease control TerminatedThis study was designed to test two drugs, regorafenib and lorigerlimab, in people whose rectal cancer had come back or was growing after initial treatment. The goal was to see if the combination was safe and effective. However, the trial was withdrawn before enrolling any partic…
Matched conditions: RECTAL CANCER RECURRENT
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
New study aims to make complex pelvic cancer surgery safer
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at ways to improve the surgical process and recovery for people with advanced or recurrent rectal cancer that has spread to nearby organs. It involves 24 adults who need a major operation called pelvic exenteration to remove all cancer. The goal is to standardize…
Matched conditions: RECTAL CANCER RECURRENT
Sponsor: Chang Gung Memorial Hospital • Aim: Knowledge-focused
Last updated May 06, 2026 16:02 UTC